BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
47 hedge funds and large institutions have $16.9M invested in Baudax Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-6
Holders Change %
-11.32%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
10
Increased
13
Reduced
10
Closed
15
Calls
$2.13M
Puts
$37K
Net Calls
+$2.09M
Net Calls Change
+$2.09M
Top Buyers
| 1 |
NRC
North Run Capital
Boston,
Massachusetts
|
+$2.22M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.51M |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.07M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$992K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$927K |
Top Sellers
| 1 |
ECM
Engine Capital Management
New York
|
-$2.53M |
| 2 |
NM
Newtyn Management
New York
|
-$1.93M |
| 3 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$1.32M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$761K |
| 5 |
Renaissance Technologies
New York
|
-$663K |
